|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 655 K Street NW, Suite 100 |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20001-2399 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 4493-12
|
||||||||
|
6. House ID# 312430000
|
TYPE OF REPORT | 8. Year | 2025 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Leonard Marquez |
Date | 4/21/2025 9:28:33 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ANI
16. Specific lobbying issues
Issue: Support research with non-human primates and other animals.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tannaz |
Rasouli |
|
|
|
Andrew |
Herrin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
P.L.118-5 - Fiscal Responsibility Act of 2023
Issue: Oppose cuts to discretionary spending.
Issue: Ensure robust non-defense discretionary spending levels and for the Labor HHS spending bill.
S.862 - Restoring Americas Health Care Workforce and Readiness Act
Issue: Support extension of National Health Service Corps (NHSC) funding.
Issue: Support providing discretionary funds for rural teaching hospitals to expand their residency programs.
P.L.119-4 - Full-Year Continuing Appropriations and Extensions Act, 2025
P.L.118-158 - American Relief Act 2025
S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
H.R.9029 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Issue: Support increased funding for National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), Childrens Hospitals Graduate Medical Education (CHGME), Centers for Disease Control and Prevention (CDC), Hospital Preparedness Program, and biodefense, emerging special pathogens and public health preparedness programs. Support mandatory funding for public health preparedness. Oppose limitations on facilities and administrative reimbursement. Maintain NIH salary cap at Executive Level II. Support animal research and oppose efforts to increase burden on researchers unnecessarily. Ensure investment in Advanced Research Projects Agency for Health (ARPA-H) does not supplant NIH funding. Support funding for Health Resources and Services Administration (HRSA) Title VII and VIII workforce programs. Support funding for CDC Social Determinants of Health program (SDOH), Prevention Research Centers, hospital-based and community violence interventions, data modernization, advanced molecular detection, outbreak forecasting, and climate and health, and gun violence prevention research. Support ongoing investment in public health infrastructure. Support funding for maternal health. Support expansion of CDC-supported genomic sequencing. Support robust 302(b) allocation and funding for non-defense discretionary programs. Support funding for telehealth resource centers. Support funding for the National Health Service Corps (NHSC) and Teaching Health Centers Graduate Medical Education (THCGME). Support disbursement of appropriated funding.
H.R.8771/S.4797 - Department of State, Foreign Operations, and Related Programs Appropriations Act, 2025
Issue: Oppose efforts to limit certain types of medical research.
P.L.119-4 - Full-Year Continuing Appropriations and Extensions Act, 2025
H.R.9026 - House FY 2025 Commerce and Justice, Science, and Related Agencies Spending Bill
S.4795 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025
Issue: Support funding for the National Science Foundation (NSF).
P.L.119-4 - Full-Year Continuing Appropriations and Extensions Act, 2025
FY 2025 Presidents Request on Military Construction, Veterans Affairs, and Related Agencies
H.R.8580 FY 2025 Military Construction, Veterans Affairs (VA), and Related Agencies Appropriations Act
S.4677 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2025
Issue: Support increased funding for the VA Medical and Prosthetic Research Program and funding to preserve animal research. Support allocation of resources to VA to address funding shortfall.
FY 2026 Presidents Request on Military Construction, Veterans Affairs, and Related Agencies
House and Senate FY 2026 Military Construction, Veterans Affairs, and Related Agencies Appropriations Bill
Issue: Support increased funding for the VA Medical and Prosthetic Research Program and funding to preserve animal research. Support allocation of resources to VA to address funding shortfall.
Issue: Prevent rescissions of COVID relief funding.
Issue: Support restoration and continuation of funding for the 21st Century Cures Act.
Presidents FY 2026 Budget Request
House and Senate FY 2026 Labor, Health and Human Services, and Education, and Appropriations Bill
Issue: Support increased funding for National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), Childrens Hospitals Graduate Medical Education (CHGME), Centers for Disease Control and Prevention (CDC), Hospital Preparedness Program, and biodefense, emerging special pathogens and public health preparedness programs. Oppose limitations on facilities and administrative reimbursement. Maintain NIH salary cap at Executive Level II. Support animal research and oppose efforts to increase burden on researchers unnecessarily. Ensure investment in Advanced Research Projects Agency for Health (ARPA-H) does not supplant NIH funding. Support funding for Health Resources and Services Administration (HRSA) Title VII and VIII workforce programs. Support robust 302(b) allocation and funding for non-defense discretionary programs. Support disbursement of appropriated funds.
Presidents FY 2026 Budget Request
House and Senate FY 2026 Commerce, Justice, Science, and Related Agencies Appropriations Bill
Issues: Support funding for the National Science Foundation (NSF).
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Health Resources & Services Administration (HRSA), Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Veterans Affairs - Dept of (VA), Food & Drug Administration (FDA), Office of Science & Technology Policy (OSTP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tannaz |
Rasouli |
|
|
|
Len |
Marquez |
|
|
|
Ally |
Perleoni |
|
|
|
Andrea |
Price-Carter |
|
|
|
Danielle |
Turnipseed |
|
|
|
Sinead |
Hunt |
|
|
|
Devan |
O'Toole |
|
|
|
Andrew |
Herrin |
|
|
|
Emily |
Prest |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
Issues: Support affordable income driven repayment plans for borrowers and the ability for student borrowers to borrow up to the cost of attendance. Oppose cuts to graduate/professional student loan and repayment plans, including Public Service Loan Forgiveness (PSFL), and elimination of Direct PLUS loans, and long-standing tax deductions. Oppose limitations to institutions financial aid access based on tax status.
H.R.2106/S.975 - Expanding Medical Education Act
Issue: Support grants to create, expand, and support medical schools and regional medical campuses, including minority serving institutions (MSIs).
Issue: Support the elimination of taxes on non-tuition student scholarship and grant aid.
Issue: Oppose limiting financial aid access for students at institutions subject to the endowment tax.
Issue: Support reinstating graduate student eligibility for Federal Direct Subsidized Loans.
Issue: Oppose elimination of Direct PLUS loans and other limitations on graduate/professional borrowing. Support eliminating student loan origination fees and interest capitalization.
Issue: Support loan repayment incentives for rural health care providers.
Issue: Support tax incentives for clinical preceptors.
Issue: Support Public Service Loan Forgiveness (PSLF) eligibility for enrollees in income driven loan repayment programs, including SAVE.
Issue: Support delay in implementation of reporting requirement in financial value transparency and gainful employment regulations.
H.R.1048 DETERRENT Act
Issue: Oppose expanding current college foreign gift reporting requirements under Section 117 of the Higher Education Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Education - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Danielle |
Turnipseed |
JD |
|
|
Tannaz |
Rasouli |
|
|
|
Len |
Marquez |
|
|
|
Ally |
Perleoni |
|
|
|
Andrea |
Price-Carter |
|
|
|
Devan |
O'Toole |
|
|
|
Andrew |
Herrin |
|
|
|
Sinead |
Hunt |
|
|
|
Emily |
Prest |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issue: Educate Congress on how the 340B Drug Pricing Program helps safety-net providers to fulfill their missions and care for patients and communities. Support measures to preserve and strengthen the 340B Drug Pricing Program. Support measures to prevent pharmacy benefit managers and commercial insurers from imposing discriminatory reimbursement policies on 340B covered entities. Support amending the 340B statute to codify covered entities ability to use contract pharmacies.
Issue: Oppose efforts to reduce the scope of the program and transition 340B into a rebate model. Oppose efforts to impose additional reporting requirements on 340B hospitals. Oppose efforts to restrict 340B patient definition. Oppose efforts to restrict hospital eligibility for the 340B program.
Issue: Oppose insurance plans that do not meet Affordable Care Act requirements.
Issue: Support policies to improve maternal health outcomes through expanded Medicaid coverage, enhanced data collection, and improved access to behavioral health care during the perinatal period.
Issue: Educate Congress on development of laboratory developed tests (LDTs) at academic medical centers and oppose policies that would increase burdensome regulations and negatively impact patients access to care by allowing FDA regulation of the development of LDTs at academic medical centers.
Issue: Educate Congress on the medical education and training continuum, the annual residency Match, and the role of the National Resident Matching Program (NRMP) in medical education and residency.
Issue: Provide guidance on the implementation of the No Surprises Act (P.L.116-260).
Issue: Educate Congress and the administration on the role of academic medicine in the provision of mental and behavioral health care, including initiatives to respond to the opioid epidemic. Support policies to strengthen the behavioral health workforce, promote the uptake of integrated behavioral health models, advance mental health research, and ensure access to coverage and care.
Issue: Educate Congress about the financial challenges facing academic medical centers, including reimbursement challenges, workforce challenges, inflation, and others.
Issue: Educate Congress and the administration about the impact of the unwinding of the COVID-19 public health emergency on the academic medicine community and the patients they serve.
Issue: Support reauthorization of the Childrens Hospitals Graduate Medical Education (CHGME) program.
Issue: Support reauthorization of the National Health Service Corps (NHSC) and Teaching Health Center Graduate Medical Education (THCGME).
Issue: Support maintaining membership in the World Health Organization.
Issue: Urge full staffing and funding for health, public health, and research agencies.
Issue: Educate Congress and the administration about medical education on nutrition, hunger, and health; reproductive health; substance use disorders; medication assisted treatment for opioid use disorders; trans health; preventing fraud and abuse; diversity, equity, and inclusion; menopause management; health care for people with disabilities; and maternal health.
Issue: Educate Congress on resident expectations related to clinical practice and oppose so-called physician service mandates.
Issue: Support codification of Health Resources & Services Administrations (HRSA) rural residency planning and development program.
Issue: Support providing discretionary funds for rural teaching hospitals to expand their residency programs.
Issue: Encourage changes to Health Resources & Services Administration (HRSA) financial aid programs as a result of FAFSA updates.
Issue: Educate Congress on the use of artificial intelligence (AI) in academic medicine.
Draft Providing Resources and Opportunities for Health Education and Learning (PRO-HEAL) Act
Issue: Support Health Resources & Services Administration (HRSA) grants to expand provider pipeline programs to create pathways to health care careers.
H.R.929/S.266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Issue: Support ability of Health Resources & Services Administration (HRSA) to implement evidenced-based practices for preventing suicide and improving mental health and resiliency among health care professionals, and for training health care professionals in appropriate strategies to address substance use disorders.
Draft EMPOWER for Health Act
Issue: Support reauthorization of the Health Resources & Services Administration (HRSA) Title VII health professions programs.
Issue: Support reauthorization of the Health Resources & Services Administration (HRSA) Title VIII nursing workforce development programs.
S.331 - HALT Fentanyl Act
Issue: Educate Congress on research and schedule I substances.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), Health Resources & Services Administration (HRSA), Centers For Medicare and Medicaid Services (CMS), Natl Institutes of Health (NIH), Substance Abuse & Mental Health Services Administration (SAMHSA), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), Executive Office of the President (EOP), Office of Natl Drug Control Policy (NDCP), Office of Science & Technology Policy (OSTP), Agency for Healthcare Research & Quality (AHRQ), White House Office, Vice President of the U.S., Natl Security Council (NSC), Natl Council on Disability
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Len |
Marquez |
|
|
|
Ally |
Perleoni |
|
|
|
Sinead |
Hunt |
|
|
|
Tannaz |
Rasouli |
|
|
|
Danielle |
Turnipseed |
JD |
|
|
Andrea |
Price-Carter |
|
|
|
Andrew |
Herrin |
|
|
|
Devan |
O'Toole |
|
|
|
Emily |
Prest |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
H.R.1585/S.709 - Conrad State 30 and Physician Access Reauthorization Act
Issue: Support expansion of the Conrad 30 program and improvements to physician immigration.
H.R.1201- Doctors in Our Borders Act
Issue: Support expansion of the Conrad 30 program and improvements to physician immigration. Educate Congress on policies allowing undocumented students to attend U.S. medical schools and graduate medical education.
Issue: Support permanent protections for Deferred Action for Childhood Arrivals (DACA) recipients.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Len |
Marquez |
|
|
|
Tannaz |
Rasouli |
|
|
|
Ally |
Perleoni |
|
|
|
Andrea |
Price-Carter |
|
|
|
Emily |
Prest |
|
|
|
Danielle |
Turnipseed |
JD |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Issue: Educate Congress and the administration about the impact of regulatory burden on medical research.
Issue: Oppose inappropriate use of march-in authority.
Issue: Educate Congress and the administration about opportunities to strengthen medical research supported by National Institutes of Health (NIH).
Issue: Provide input on proposed National Institutes of Health (NIH) optimization frameworks.
H.R.1864/S.854 - Risky Research Review Act
Issue: Support prevention of unintended consequences from new restrictions on life sciences research.
H.R.1863/S.855 - Royalty Transparency Act
Issue: Support technical correction to ensure bill does not paralyze National Institutes of Health (NIH) peer review system.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), White House Office, Executive Office of the President (EOP), Office of Science & Technology Policy (OSTP), Commerce - Dept of (DOC), Natl Institute of Standards & Technology (NIST)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tannaz |
Rasouli |
|
|
|
Danielle |
Turnipseed |
JD |
|
|
Andrew |
Herrin |
|
|
|
Devan |
O'Toole |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Fiscal Year 2025 Budget Reconciliation
H. Con. Res. 14
Issue: Educate Congress on potential financial implications of Medicare and Medicaid cuts and entitlement reform on teaching hospitals and health systems, medical schools, and faculty practices and the impact on patients access to care and the nations health. Support preservation of nonprofit tax status for Association of American Medical Colleges (AAMC) member teaching health systems and hospitals with federal non-profit status. Oppose reduction in Medicare hospital outpatient department reimbursement and site-neutral expansion to excepted off-campus provider-based departments (PBDs). Oppose creation of National Provider Number/unique identifier for off-campus hospital outpatient departments. Oppose Medicare hospital, and provider cuts including Medicare graduate medical education (GME) reforms, reduction or elimination of bad debt reimbursement, reforming Medicare disproportionate share hospital payments and uncompensated care, prevention of rural reclassification, reductions in wage index. Oppose work or other community engagement activities as a requirement for continued Medicaid eligibility or coverage, restrictions on provider taxes, limits on state directed payments, reductions in the Federal Medical Assistance Percentage (FMAP), and the implementation of per-capita caps and/or block grants. Oppose reducing Medicare reimbursement for 340B-acquired drugs.
Issue: Educate Congress and policymakers on the financial challenges facing teaching hospitals and health systems, medical schools, and faculty practices and the impact on patients access to care and the nations health.
Issue: Support increased Medicare funding for graduate medical education (GME).
Draft Bipartisan Senate Medicare GME Expansion proposal
Issue: Support increased Medicare funding for graduate medical education (GME). Oppose duplicative teaching health system and hospital reporting and policies that increase regulatory burden.
H.R.2314 - Fair Access in Residency Act
Issue: Oppose legislative interference in residency training program requirements and policies requiring the Medicare program to consider specific physician licensing exams for residency program applications.
H.R.1153 - Rural Physician Workforce Production Act
Issue: Oppose legislation redesigning Medicare graduate medical education (GME) payment formulas that reduce current Direct Graduate Medical Education (DGME) and Indirect Medical Education (IME) payments to teaching hospitals.
Issue: Educate Congress on teaching health system and hospital graduate medical education (GME) data collection practices and concerns related to duplicative reporting requirements.
Safety From Violence for Healthcare Employees (SAVE) Act
Issue: Support legislation providing protection for health care workers by creating a criminal offense for knowingly assaulting or intimidating hospital workers and providing grants to reduce violence in hospitals.
Issue: Oppose legislation that pays for workforce investments and mitigation of Medicaid Disproportionate Share Hospital (DSH) program cuts paid for by cuts to hospital outpatient departments.
Issue: Support legislation that ensures the continued move to value-based care.
Issue: Educate Congress about the likely impact of legislation that would alter the distribution of Medicare-supported graduate medical education (GME) slots from the Consolidated Appropriations Act (CAA), 2021 and 2023.
Issue: Educate Congress on status of Centers For Medicare and Medicaid Services (CMS) distribution of the 1,000 new graduate medical education (GME) slots authorized by the Consolidated Appropriations Act (CAA), 2021 (P.L.116-260). Support CMS changing its distribution methodology to end the practice of super prioritization.
Issue: Support Medicare graduate medical education (GME) per resident amount and cap-setting technical corrections and administrative relief.
Issues: Support lifting cap on number of residents Medicare will count when determining teaching hospitals' Medicare Direct Graduate Medical Education (DGME) and Indirect Medical Education (IME) payments.
Issue: Oppose reduction of Medicare Direct Graduate Medical Education (DGME) and Indirect Medical Education (IME) payments.
Issue: Oppose the redesign of Medicare Indirect Medical Education financing and redistribution.
Issue: Oppose establishing nationality-based restrictions on medical residencies supported by Medicare.
Issue: Support creation of new Medicare outpatient Indirect Medical Education (IME) payment in addition to existing Medicare IME payment inpatient methodology. Oppose policies to create budget neutral IME payments for outpatient services.
Issue: Support efforts to reform the Medicare physician fee schedule.
H.R. 879 - Medicare Patient Access and Practice Stabilization Act of 2025
Issue: Support Medicare Physician Fee Schedule (PFS) reform.
P.L. 119-4 - Full-Year Continuing Appropriations and Extensions Act, 2025
P.L. 118-158 - American Relief Act 2025
Issues: Oppose reduction in Medicare hospital outpatient department reimbursement for drug administration and other services. Oppose site-neutral expansion to excepted off-campus provider-based departments (PBDs). Oppose creation of National Provider Number/unique identifier for off-campus hospital outpatient departments. Oppose Medicare hospital, and provider cuts. Support mitigation of Medicare Physician Fee Schedule (PFS) cuts. Support delaying or eliminating scheduled cuts to the Medicaid disproportionate share hospital (DSH) program. Support extension of alternative payment model (APM) bonus. Support allowing hospitals to count costs and reimbursements for Medicaid patients with third-party coverage towards their DSH cap. Support extensions of Acute Hospital at Home program waiver of 24/7 nursing requirement and Medicare telehealth waivers and efforts to expand patient access to telehealth.
Issue: Educate Congress on role of academic medicine as it relates to price transparency or disclosure initiatives.
Issue: Protect patients from delays in care by streamlining and standardizing prior authorization under the Medicare Advantage program and providing program oversight and transparency.
Issue: Support elimination of scheduled reductions to the Medicaid disproportionate share hospital (DSH) program.
Issue: Support allowing hospitals to count costs and reimbursements for Medicaid patients with third-party coverage towards their disproportionate share hospital (DSH) cap.
Issue: Support necessary changes and improvements to the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
Issue: Support policies to close the Medicaid coverage gap and ensure access to coverage in non-expansion states, as well as financial incentives to help states maintain existing expansions. Support mandatory 12-month Medicaid coverage for post-partum individuals.
Issue: Oppose efforts by states to impose work or other community engagement activities as a requirement for continued Medicaid eligibility or coverage for certain Medicaid beneficiaries.
Issue: Support waiving budget neutrality requirements associated with the E/M code changes or temporarily holding harmless physicians and other health care professionals.
Issue: Support extension of Acute Hospital at Home program waiver of 24/7 nursing requirement.
Issue: Support extension of Medicare telehealth waivers and efforts to expand patient access to telehealth.
Issue: Support policy to permanently remove requirement for Medicare beneficiaries to be seen in-person every six months for telehealth visits for mental health services.
Issue: Support legislation to eliminate the 190-day Lifetime Limit policy in the Medicare program.
Issue: Support providing states with guidance to increase telehealth access in Medicaid and CHIP.
Issue: Support increased access to behavioral health and substance use disorder treatment services under Medicare and Medicaid. Support the removal of regulatory barriers to telehealth-enabled mental health care, including electronic interprofessional consults (eConsults).
Issue: Support legislation to modify Medicare payment rates for clinical diagnostic laboratory services to avoid statutory cuts to these payments.
Issue: Support authorization of Medicare advance and accelerated payments in the wake of cyberattacks on providers.
Issue: Support removing cost-sharing obligations from the chronic care management (CCM) code in Medicare.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Len |
Marquez |
|
|
|
Ally |
Perleoni |
|
|
|
Sinead |
Hunt |
|
|
|
Tannaz |
Rasouli |
|
|
|
Danielle |
Turnipseed |
JD |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Issue: Educate Congress on the importance of the Veterans Affairs (VA) academic affiliates to improve veteran care through clinical, research, and education partnerships.
Issue: Discuss opportunities to support local affiliations between academic medical centers and Veterans Affairs (VA) medical centers.
Issue: Oppose burdensome administrative requirements for Veterans Affairs (VA) researchers related to Section 208, 205, and 203 waivers.
Issue: Oppose limitations on animal research.
Issue: Oppose disruptions to Veterans Affairs (VA) clinical care, education and training, and research workforce as a result of agency restructuring.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tannaz |
Rasouli |
|
|
|
Len |
Marquez |
|
|
|
Ally |
Perleoni |
|
|
|
Danielle |
Turnipseed |
JD |
|
|
Andrew |
Herrin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Issue: Support preservation of nonprofit tax status for Association of American Medical Colleges (AAMC) member teaching health systems and hospitals with federal non-profit status.
Issue: Educate Congress and policymakers on academic medical centers, teaching health systems and hospitals, medical schools, and faculty physicians unique role in patient care, education, research, and community collaboration. Explain the societal and community benefit related to such activities.
Issue: Support tax exempt status for higher education institutions.
H.R.593 Strengthening Pathways to Health Professions Act
Issue: Support extending tax-exempt status to certain Health Resources and Services Administration (HRSA) health workforce education scholarship and loan programs.
Issue: Support incentives for clinicians volunteering to be preceptors for medical students.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Len |
Marquez |
|
|
|
Ally |
Perleoni |
|
|
|
Sinead |
Hunt |
|
|
|
Danielle |
Turnipseed |
JD |
|
|
Tannaz |
Rasouli |
|
|
|
Devan |
O'Toole |
|
|
|
Andrea |
Price-Carter |
|
|
|
Emily |
Prest |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |